FDA Approves VANCOMYCIN HYDROCHLORIDE — Baxter Healthcare Corporation

# FDA Approves Baxter Healthcare's Vancomycin Hydrochloride for Intravitreal Injection Baxter Healthcare Corporation received FDA approval for Vancomycin Hydrochloride as an intravitreal injection, expanding treatment options for serious ocular infections and potentially strengthening the company's position in the specialty pharmaceutical market. The approval addresses a significant gap in ophthalmic therapeutics, as intravenous vancomycin penetration to the eye is limited, creating a substantial market opportunity for localized ocular antimicrobial therapy.